Cabergoline
- Product NDC
- 50090-5834
- 11-digit product format
- 500905834
- Labeler code
- 50090
- Product ID
- 50090-5834_2f4ab4e8-63aa-4382-90e7-7657b52c69f9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cabergoline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA204735
- Marketing category
- ANDA
- Marketing start
- 2018-08-09
- Substance
- CABERGOLINE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Ergolines [CS], Ergot Derivative [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cabergoline
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CABERGOLINE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LL60K9J05T |
| Rxcui | 199703 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5834-0 | Cabergoline | 8 in 1 BOTTLE | TABLET | 8 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5834 | CABERGOLINE TABLET [A-S MEDICATION SOLUTIONS] | 6 | Current NDC, Legacy NDC, 1 package rows | 20230414_89ec147b-a6fe-49bb-9af5-52fc2ce5db7f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5834-0 | 50090583400 | 8 TABLET in 1 BOTTLE (50090-5834-0) | 8 tablet | 2021-10-27 | 0000-00-00 | No | No | Current |